Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mediators Inflamm
2014 Jan 01;2014:506450. doi: 10.1155/2014/506450.
Show Gene links
Show Anatomy links
TRPV1 antagonism by capsazepine modulates innate immune response in mice infected with Plasmodium berghei ANKA.
Fernandes ES
,
Brito CX
,
Teixeira SA
,
Barboza R
,
dos Reis AS
,
Azevedo-Santos AP
,
Muscará M
,
Costa SK
,
Marinho CR
,
Brain SD
,
Grisotto MA
.
Abstract
Thousands of people suffer from severe malaria every year. The innate immune response plays a determinant role in host''s defence to malaria. Transient receptor potential vanilloid 1 (TRPV1) modulates macrophage-mediated responses in sepsis, but its role in other pathogenic diseases has never been addressed. We investigated the effects of capsazepine, a TRPV1 antagonist, in malaria. C57BL/6 mice received 10(5) red blood cells infected with Plasmodium berghei ANKA intraperitoneally. Noninfected mice were used as controls. Capsazepine or vehicle was given intraperitoneally for 6 days. Mice were culled on day 7 after infection and blood and spleen cell phenotype and activation were evaluated. Capsazepine decreased circulating but not spleen F4/80(+)Ly6G(+) cell numbers as well as activation of both F4/80(+)and F4/80(+)Ly6G(+) cells in infected animals. In addition, capsazepine increased circulating but not spleen GR1(+) and natural killer (NK) population, without interfering with natural killer T (NKT) cell numbers and blood NK and NKT activation. However, capsazepine diminished CD69 expression in spleen NKT but not NK cells. Infection increased lipid peroxidation and the release of TNFα and IFNγ, although capsazepine-treated group exhibited lower levels of lipid peroxidation and TNFα. Capsazepine treatment did not affect parasitaemia. Overall, TRPV1 antagonism modulates the innate immune response to malaria.
Figure 1. Effect of capsazepine on parasitaemia levels. Parasitaemia was measured daily, from day 5 to day 7 after infection in blood smear samples obtained from C57BL/6 mice infected with Plasmodium berghei ANKA (105 infected RBCs/animal; i.p.) treated with either capsazepine (50 μg/animal, 2x day, for 6 days) or vehicle (10% DMSO in saline) from 24 h after infection (n = 8 per group).
Bird,
Comparative studies on different methods of malonaldehyde determination.
1984, Pubmed
Bird,
Comparative studies on different methods of malonaldehyde determination.
1984,
Pubmed
Bryant,
Capsaicin-sensitive nerves regulate the metabolic response to abdominal sepsis.
2003,
Pubmed
Chua,
Monocytes and macrophages in malaria: protection or pathology?
2013,
Pubmed
Clark,
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin.
2007,
Pubmed
Clark,
How TNF was recognized as a key mechanism of disease.
2007,
Pubmed
Coban,
Manipulation of host innate immune responses by the malaria parasite.
2007,
Pubmed
Docherty,
Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture.
1997,
Pubmed
Elias,
Oxidative stress and modification of renal vascular permeability are associated with acute kidney injury during P. berghei ANKA infection.
2012,
Pubmed
Fernandes,
A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund's complete adjuvant-induced monarthritis.
2011,
Pubmed
Fernandes,
TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome.
2012,
Pubmed
Fernandes,
Superoxide generation and leukocyte accumulation: key elements in the mediation of leukotriene B₄-induced itch by transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1.
2013,
Pubmed
Fernandes,
The functions of TRPA1 and TRPV1: moving away from sensory nerves.
2012,
Pubmed
Ferrari,
Oxidative and nitrosative stress on phagocytes' function: from effective defense to immunity evasion mechanisms.
2011,
Pubmed
Finney-Hayward,
Expression of transient receptor potential C6 channels in human lung macrophages.
2010,
Pubmed
Fischer,
CD11b⁺, Ly6G⁺ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection.
2011,
Pubmed
Frevert,
Immunobiology of Plasmodium in liver and brain.
2013,
Pubmed
Fullerton,
Pathways mediating resolution of inflammation: when enough is too much.
2013,
Pubmed
Gabrilovich,
Myeloid-derived suppressor cells as regulators of the immune system.
2009,
Pubmed
Gallo,
Simultaneous determination of phagocytosis of Plasmodium falciparum-parasitized and non-parasitized red blood cells by flow cytometry.
2012,
Pubmed
Garle,
Stimulation of dichlorofluorescin oxidation by capsaicin and analogues in RAW 264 monocyte/macrophages: lack of involvement of the vanilloid receptor.
2000,
Pubmed
Gerosa,
Reciprocal activating interaction between natural killer cells and dendritic cells.
2002,
Pubmed
Gimenez,
Tumor necrosis factor alpha in the pathogenesis of cerebral malaria.
2003,
Pubmed
Guptill,
Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis.
2011,
Pubmed
Hansen,
NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.
2007,
Pubmed
Hazen,
Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity.
2008,
Pubmed
Iida,
Attenuated fever response in mice lacking TRPV1.
2005,
Pubmed
Keeble,
Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation.
2005,
Pubmed
Leoratti,
Neutrophil paralysis in Plasmodium vivax malaria.
2012,
Pubmed
Liu,
Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia.
1997,
Pubmed
Lyke,
Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls.
2004,
Pubmed
McIntyre,
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1).
2001,
Pubmed
Moulick,
Vivax malaria presenting with myelitis: a rare complication.
2013,
Pubmed
Nassini,
Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation.
2012,
Pubmed
Percário,
Oxidative stress in malaria.
2012,
Pubmed
Pradhan,
Immunological disturbances associated with malarial infection.
2013,
Pubmed
Puntambekar,
Essential role of Rac1/NADPH oxidase in nerve growth factor induction of TRPV1 expression.
2005,
Pubmed
Russell,
Tumour necrosis factor alpha mediates transient receptor potential vanilloid 1-dependent bilateral thermal hyperalgesia with distinct peripheral roles of interleukin-1beta, protein kinase C and cyclooxygenase-2 signalling.
2009,
Pubmed
Rénia,
Cerebral malaria: mysteries at the blood-brain barrier.
2012,
Pubmed
Saunders,
Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death.
2009,
Pubmed
Schilling,
Importance of the non-selective cation channel TRPV1 for microglial reactive oxygen species generation.
2009,
Pubmed
Schofield,
Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis.
2007,
Pubmed
Schwarzer,
Malaria-parasitized erythrocytes and hemozoin nonenzymatically generate large amounts of hydroxy fatty acids that inhibit monocyte functions.
2003,
Pubmed
Sharma,
Role of oxidative stress and apoptosis in the placental pathology of Plasmodium berghei infected mice.
2012,
Pubmed
Shikani,
Cerebral malaria: we have come a long way.
2012,
Pubmed
Starr,
A reactive oxygen species-mediated component in neurogenic vasodilatation.
2008,
Pubmed
Stevenson,
Innate immunity to malaria.
2004,
Pubmed
Susankova,
Reducing and oxidizing agents sensitize heat-activated vanilloid receptor (TRPV1) current.
2006,
Pubmed
Tsuji,
Role of transient receptor potential vanilloid 1 in inflammation and autoimmune diseases.
2012,
Pubmed
Van Ginderachter,
Myeloid-derived suppressor cells in parasitic infections.
2010,
Pubmed
Villadangos,
Hold on, the monocytes are coming!
2007,
Pubmed
Vitale,
NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.
2005,
Pubmed
Wang,
TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats.
2008,
Pubmed
Yang,
Study on TRPV1-mediated mechanism for the hypersecretion of mucus in respiratory inflammation.
2013,
Pubmed
Yang,
Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.
2013,
Pubmed
Zhao,
Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α.
2013,
Pubmed
